InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Hansard Adam, Directeur Commercial. Officer active across 2 companies, notably Applied Therapeutics Inc.. Aggregated, 13 reports have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €358k. Activity tracked since 26 May 2021. The latest transaction was disclosed on 14 March 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
48,871 shares@ US$5.39100.0% of flowCommon StockSEC:0001096906-24-000493:0
400,000 shares0Common StockSEC:0001209191-23-059634:0
965 shares@ US$1.971.5% of flowCommon StockSEC:0001209191-23-057115:0
9,720 shares@ US$2.7021.6% of flowCommon StockSEC:0001209191-23-050890:0
4,495 shares@ US$0.913.2% of flowCommon StockSEC:0001209191-23-003288:0
31,700 shares0Common StockSEC:0001209191-22-002968
31,700 shares0Common StockSEC:0001209191-22-002964
31,700 shares0Common StockSEC:0001209191-22-002968:0
31,700 shares0Common StockSEC:0001209191-22-002964:0
31,700 shares0Common StockSEC:0001209191-21-070086
31,700 shares0Common StockSEC:0001209191-21-070086:0
2,894 shares@ US$18.3550.0% of flowCommon StockSEC:0001209191-21-036685:0
2,894 shares@ US$18.3550.0% of flowCommon StockSEC:0001209191-21-036685
13 of 13 declarations
About Hansard Adam
Adam Hansard is the Chief Commercial Officer at Applied Therapeutics Inc. He is responsible for the company's commercial strategy, aiming to maximize growth opportunities and strengthen the company's market position. Adam brings expertise in marketing and business development, contributing to the development of effective strategies to achieve the company's objectives. His experience in the biotechnology sector enables him to navigate a competitive environment and make informed decisions for the company's future.
